Enjoy 5 days packed with science, clinical updates, and networking opportunities.

The AD/PD™ series of conferences have always been notable for an excellent program that balances cutting-edge scientific research and advanced clinical discussions.

This tradition continues in our upcoming edition with sessions on the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.

Join us on March 17-21, 2026, in the wonderful city of Copenhagen, Denmark for AD/PD™ 2026.

The Conference program starts at 8:30 AM on Tuesday, March 17th.

Program at a Glance

Get a quick overview of the program.

BROWSE

Interactive Program

Dive into the complete program.

EXPLORE

Please note the program is subject to changes.

Join us at the leading international event dedicated to neurodegenerative diseases.

The world’s foremost experts in neurology and neuroscience will gather and present the latest advances in the science and therapy of Alzheimer’s, Parkinson’s, Huntington’s, Amyotrophic lateral sclerosis, Frontotemporal Dementia, Lewy body dementia and other related neurodegenerative diseases.

REGISTER TODAY

100+

Speakers

82

Symposia

17

Industry symposia

7

Forum discussions

6

Plenary lectures

AD/PD™ is an inspiring convergence of cutting-edge science and real-world clinical application. I was most impressed by the integration of neurodegeneration biomarkers with precision medicine approaches, offering hope for earlier and more targeted interventions. The collaborative spirit and energy among researchers, clinicians, and innovators truly stood out — it felt like the future of brain health is being shaped right now.

I especially appreciated the diversity and depth of the scientific content. The integration of basic and translational research with updates on clinical trials created a well-rounded perspective on neurodegenerative disease research. I also enjoyed the opportunities for networking and collaboration, as well as the accessibility of sessions both in person and virtually. The possibility of seeing the virtual sessions was particularly important.

Excellent mix of very mechanistic science, translational work, and clinical research. It truly bridged the gap between lab and clinic.

The scientific program is fascinating. Diverse topics and research lines are addressed and brilliantly generate new questions at the same time as answering some.

Great overview of new treatments and biomarkers from industry and academia, all of which are well integrated.

Be part of this leading international event

Whether you are an established professional looking to update your expertise, or an emerging researcher or clinician seeking to connect with mentors, AD/PD™ 2026 promises a dynamic, interactive, and informative experience for all.

JOIN THE PROGRAM